Market Watch: Evolent Health Inc (EVH)’s Noteworthy Drop, Closing at 23.75

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

As of close of business last night, Evolent Health Inc’s stock clocked out at $23.75, down -2.90% from its previous closing price of $24.46. In other words, the price has decreased by -$2.90 from its previous closing price. On the day, 2.56 million shares were traded. EVH stock price reached its highest trading level at $25.6 during the session, while it also had its lowest trading level at $23.73.


To gain a deeper understanding of EVH’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.16. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.02. In the meantime, Its Debt-to-Equity ratio is 0.79 whereas as Long-Term Debt/Eq ratio is at 0.77.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on April 22, 2024, initiated with a Buy rating and assigned the stock a target price of $40.

On March 01, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $45.

On January 03, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $39.Barclays initiated its Overweight rating on January 03, 2024, with a $39 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 05 ’23 when Blackley Seth sold 141,000 shares for $26.54 per share. The transaction valued at 3,741,475 led to the insider holds 637,645 shares of the business.

McCarthy Daniel Joseph sold 11,000 shares of EVH for $330,000 on Nov 15 ’23. The PRESIDENT now owns 198,333 shares after completing the transaction at $30.00 per share. On Aug 15 ’23, another insider, Rafferty Emily Ann, who serves as the Chief Operating Officer of the company, sold 7,900 shares for $28.05 each. As a result, the insider received 221,595 and left with 70,897 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EVH now has a Market Capitalization of 2723555072 and an Enterprise Value of 3382757120. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.27 while its Price-to-Book (P/B) ratio in mrq is 2.60. Its current Enterprise Value per Revenue stands at 1.555 whereas that against EBITDA is 27.405.

Stock Price History:

Over the past 52 weeks, EVH has reached a high of $35.83, while it has fallen to a 52-week low of $23.33. The 50-Day Moving Average of the stock is -22.67%, while the 200-Day Moving Average is calculated to be -18.69%.

Shares Statistics:

It appears that EVH traded 1.02M shares on average per day over the past three months and 1610300 shares per day over the past ten days. A total of 113.89M shares are outstanding, with a floating share count of 110.27M. Insiders hold about 5.10% of the company’s shares, while institutions hold 108.82% stake in the company. Shares short for EVH as of 1714435200 were 11254158 with a Short Ratio of 11.08, compared to 1711584000 on 10606384. Therefore, it implies a Short% of Shares Outstanding of 11254158 and a Short% of Float of 11.03.

Most Popular

[the_ad id="945"]